18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells

Medical Science Monitor

Volumn 18, Issue 1, 2012, Pages

  Qu, Ying ^a   Chen, Wei Hua ^a   Zong, Lei ^a   Xu, Ming Yi ^a   Lu, Lun Gen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

18 GL; 18 Glycyrrhizin; Apoptosis; Hepatic stellate cell; Hepatocyte; Proliferation

Indexed keywords

18ALPHA GLYCYRRHIZIN; ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MEGADOSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER FIBROSIS; LOW DRUG DOSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; STELLATE CELL;

EID: 84855279840     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882196     Document Type: Article

References (33)

1. Friedman SL: Liver fibrosis from bench to bedside. J Hepatol, 2003; 38: S38-53
2. Gressner AM: The cell biology of liver fibrogenesis an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res, 1998; 292: 447-52
3. Eisenbrand G: Glycyrrhizin. Mol Nutr Food Res, 2006; 50: 1087-88
4. Wu X, Zhang L, Gurley E et al: Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology, 2008; 47(6): 1905-15
5. Scheuer PJ: Classification of chronic viral hepatitis: a need for reassessment. J Hepatol, 1991; 13: 372-74
6. Huang HF, Linsenmeyer TA, Li MT et al: Acute effects of spinal cord injury on the pituitary-testicular hormone axis and Sertoli cell functions: a time course study. J Androl, 1995; 16: 148-57
7. Schmittgen TD, Zakrajsek BA, Mills AG et al: Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods. Analytical Biochemistry, 2000; 285: 194-204
8. Van Rossum TGJ, Vulto AG, De Man RA et al: Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther, 1998; 12: 199-205
9. Lin G, Nnane IP, Cheng TY: The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats. Toxicon, 1999; 37: 1259-70
10. Luk JM, Zhang QS, Lee NP et al: Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in bile duct liGLtion rat model. Liver Int, 2007; 27: 548-57
11. Wang JY, Zhang QS, Guo JS et al: Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats. World J Gastroenterol, 2001; 7: 115-19
12. Fiore C, Eisenhut M, Krausse R et al: Antiviral effects of Glycyrrhiza species. Phytother Res, 2008; 22: 141-48
13. Lee JR, Park SJ, Lee HS et al: Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats. Evid Based Complement Alternat Med, 2009; 6: 195-201
14. Abe M, Akbar SMF, Hasebe A et al: Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis. J Gastroenterol, 2003; 38: 962-67
15. Dai JH, Iwatani Y, Ishida T et al: Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology, 2001;103: 235-43
16. Elsharkawy AM, Oakley F, Mann DA: The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis, 2005; 10: 927-39
17. Reeves HL, Friedman SL: Activation of hepatic stellate cells A key issue in liver fibrosis. Front Biosci, 2002;7: D808-D826.
18. Kisseleva T, Brenner DA: Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol, 2006; 21: S84-87
19. Li JT, Liao ZX, Ping J et al: Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol, 2008; 43: 419-28
20. Hagens WI, Beljaars L, Mann DA et al: Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers. J Pharmacol Exp Ther, 2008; 324: 902-10
21. Baldwin AS: The transcription factor NF-kappa B and human disease. J Clin Invest, 2001; 107(1): 3-6
22. Oakley F, Meso M, Iredale JP et al: Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology, 2005; 128(1): 108-20
23. Lang A, Schoonhoven R, Tuvia S et al: Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol, 2000; 33(1): 49-58
24. Jiang JX, Mikami K, Venugopal S et al: Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol, 2009; 51(1): 139-48
25. Oakley F, Trim N, Constandinou CM et al: Hepatocytes express nerve growth factor during liver injury Evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol, 2003; 163(5): 1849-58
26. Son G, Iimuro Y, Seki E et al: Selective inactivation of NF-kappa B in the liver using NF-kappa B decoy suppresses CCl4-induced liver injury and fibrosis. American J Physiol Gastrointest Liver Physiol, 2007; 293(3): G631-39
27. Cui DL, Zhang S, Ma JJ et al: Short interfering RNA targeting NF-kappa B induces apoptosis of hepatic stellate cells and attenuates extracellular matrix production. Dig Liver Dis, 2010; 42(11): 813-17
28. Guicciardi ME, Gores GJ: Apoptosis as a Mechanism for Liver Disease Progression. Semin Liver Dis, 2010; 30: 402-10
29. Yin XM, Ding WX: Death receptor activation-induced hepatocyte apoptosis and liver injury. Curr Mol Med, 2003; 3: 491-508
30. GLlle PR, Krammer PH: CD95-induced apoptosis in human liver disease. Semin Liver Dis, 1998; 18: 141-51
31. Ghavami S, Hashemi M, Kadkhoda K et al: Apoptosis in liver diseases detection and therapeutic applications. Med Sci Monit, 2005; 11(11): 337-45
32. Rust C, Gores GJ: Apoptosis and liver disease. Am J Med, 2000; 108(7): 567-74
33. Canbay A, Higuchi H, Bronk SF et al: Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis. Gastroenterology, 2002; 123: 1323-30